Biotransformation of chenodeoxycholic acid by human intestinal fungi and the agonistic effects on FXR

Phytochemistry. 2024 Aug:224:114162. doi: 10.1016/j.phytochem.2024.114162. Epub 2024 May 24.

Abstract

Bile acids play a vital role in modulating host metabolism, with chenodeoxycholic acid (CDCA) standing out as a primary bile acid that naturally activates farnesoid X receptor (FXR). In this study, we investigated the microbial transformations of CDCA by seven human intestinal fungal species. Our findings revealed that hydroxylation and dehydrogenation were the most prevalent metabolic pathways. Incubation of CDCA with Rhizopus microspores (PT2906) afforded eight undescribed compounds (6-13) alongside five known analogs (1-5) which were elucidated by HRESI-MS and NMR data. Notably, compounds 8, 12 and 13 exhibited an inhibitory effect on FXR in contrast to the FXR activation observed with CDCA in vitro assays. This study shone a light on the diverse transformations of CDCA by intestinal fungi, unveiling potential modulators of FXR activity with implications for host metabolism.

Keywords: Biotransformation; Chenodeoxycholic acid; FXR; Intestinal fungi.

MeSH terms

  • Biotransformation*
  • Chenodeoxycholic Acid* / chemistry
  • Chenodeoxycholic Acid* / metabolism
  • Chenodeoxycholic Acid* / pharmacology
  • Dose-Response Relationship, Drug
  • Fungi / drug effects
  • Fungi / metabolism
  • Humans
  • Intestines / microbiology
  • Molecular Structure
  • Receptors, Cytoplasmic and Nuclear* / metabolism
  • Rhizopus / metabolism
  • Structure-Activity Relationship

Substances

  • Chenodeoxycholic Acid
  • farnesoid X-activated receptor
  • Receptors, Cytoplasmic and Nuclear